Titre :
  • A lactosylated steroid contributes in vivo therapeutic benefits in experimental models of mouse lymphoma and human glioblastoma.
Auteur : Ingrassia, Laurent ; Nshimyumukiza, Prosper ; Dewelle, Janique ; Lefranc, Florence ; Wlodarczak, Lise ; Thomas, Stéphanie ; Dielie, Gwenaël ; Chiron, Christelle ; Zedde, Chantal ; Tisnès, Pierre ; van Soest, Rob ; Braekman, Jean Claude ; Darro, Francis ; Kiss, Robert
Informations sur la publication : Journal of medicinal chemistry, 49, 5, (page 1800-1807)
Statut de publication : Publié, 2006-03
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Animals
Antineoplastic Agents -- chemical synthesis
Antineoplastic Agents -- chemistry
Antineoplastic Agents -- pharmacology
Brain Neoplasms -- drug therapy
Brain Neoplasms -- mortality
Brain Neoplasms -- pathology
Cell Line, Tumor
Cell Movement -- drug effects
Cisplatin -- pharmacology
Drug Screening Assays, Antitumor
Drug Synergism
Fucose -- chemistry
Glioblastoma -- drug therapy
Glioblastoma -- mortality
Glioblastoma -- pathology
Glycosylation
Humans
Immunocompromised Host
Lactose -- chemistry
Lymphoma -- drug therapy
Lymphoma -- mortality
Lymphoma -- pathology
Mice
Neoplasm Transplantation
Steroids -- chemical synthesis
Steroids -- chemistry
Steroids -- pharmacology
Structure-Activity Relationship
Survival Rate
Transplantation, Heterologous
Note : Journal Article
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0022-2623 
info:doi/10.1021/jm050971v
info:pmid/16509595